entertainment -WSS

entertainment

author：entertainment 2025-10-02 00:28:40 - browse：88415

Senate Health, Education, Labor, and Pensions Committee Chairman Bernie Sanders looks at Moderna CEO Stephane Bancel as he testifies. Sitting next to Sanders, ranking member Sen. Bill Cassidy looks down – policy coverage from STAT — Committee Ranking Republican Bill Cassidy (La.) and Chairman Bernie Sanders (I-Vt.) Chip Somodevilla/Getty Images

WASHINGTON – The Senate health committee on Thursday passed a package of bills aimed at speeding generic drug competition and reining in drug middlemen business practices. But they failed to pass an ambitious reform to the pharmacy benefit manager sector, despite strong bipartisan support for it.

Chairman Bernie Sanders (I-Vt.) is pursuing the drug pricing reforms at the behest of Senate Majority Leader Chuck Schumer (D-N.Y.), who wants to hold a floor vote on an even bigger package of health bills later this year. The markup came just a day after the same panel held a major hearing on PBM and drugmakers’ role in high insulin prices.

It’s not clear when the Senate would take up that package, and while the package is bipartisan, it’s not clear whether it has enough support among House Republicans to pass in that chamber. There are a few, tamer PBM bills that the House Energy and Commerce Committee is expected to mark up May 17, but there is no indication that Senate and House lawmakers are coordinating on PBM legislation.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： SNAP should offer more nutrition education

leisure time

WSS

HCA sued by state AG for quality issues at Mission Health

Medicare Advantage beneficiaries sue Humana over algorithm use

Medicare drug price negotiation hasn't dried up venture capital

International team creates first chimeric human

Obesity now affects over 1 billion people worldwide, study finds

Change Healthcare cyberattack outage could last weeks

focus

entertainment

leisure time

Sports medicine is finally prioritizing gender equality

Clinical trials giant ICON acquires HumanFirst

Medicare proposal to cover medical devices draws a mixed reaction

Obesity now affects over 1 billion people worldwide, study finds

United colonoscopy coverage change 'may cost lives,' doctors say

FogPharma raises $145 million in rare Series E round

How one medical school became remarkably diverse

Kenai launches with $82 million for Parkinson’s stem cell therapy

Apple is now the first public company to be valued at $3 trillion

Bristol Myers buys into radiopharmaceuticals with RayzeBio

hotspot

Violet CEO on training clinicians to promote more inclusive care

Clinical trials giant ICON acquires HumanFirst

International team creates first chimeric human

Readout Newsletter: The latest on Moderna, Apellis, and Merck

STAT Health News: Apple Watch import ban, Pfizer fumbles, etc

Readout Newsletter: The latest on Moderna, Apellis, and Merck

focus

leisure time

explore

explore